Related references
Note: Only part of the references are listed.The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)
R. E. Steinert et al.
CLINICAL NUTRITION (2011)
Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4
Scott E. Kanoski et al.
ENDOCRINOLOGY (2011)
Sensing via intestinal sweet taste pathways
Richard L. Young
FRONTIERS IN NEUROSCIENCE (2011)
Liraglutide: the therapeutic promise from animal models
L. B. Knudsen
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Post-oral infusion sites that support glucose-conditioned flavor preferences in rats
Karen Ackroff et al.
PHYSIOLOGY & BEHAVIOR (2010)
Role of the glucagon-like-peptide-1 receptor in the control of energy balance
Matthew R. Hayes et al.
PHYSIOLOGY & BEHAVIOR (2010)
Opioid mediation of starch and sugar preference in the rat
Kristine B. Bonacchi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration
Chun-Min Lo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Intrameal Hepatic Portal and Intraperitoneal Infusions of Glucagon-Like Peptide-1 Reduce Spontaneous Meal Size in the Rat via Different Mechanisms
Elisabeth B. Ruettimann et al.
ENDOCRINOLOGY (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup et al.
LANCET (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat
V. Bucinskaite et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat
Bart C. De Jonghe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation
Matthew R. Hayes et al.
ENDOCRINOLOGY (2008)
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
Torsten P. Vahl et al.
ENDOCRINOLOGY (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size
Karen A. Scott et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Vagal innervation of intestines: afferent pathways mapped with new en bloc horseradish peroxidase adaptation
Feng-Bin Wang et al.
CELL AND TISSUE RESEARCH (2007)
The epidemiology of obesity
Cynthia L. Ogden et al.
GASTROENTEROLOGY (2007)
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not
Kirsten Raun et al.
DIABETES (2007)
Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected Ghrelin in the rat
Myrtha Arnold et al.
JOURNAL OF NEUROSCIENCE (2006)
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
L. Blonde et al.
DIABETES OBESITY & METABOLISM (2006)
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage
C Knauf et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
CCK enhances response to gastric distension by acting on capsaicin-insensitive vagal afferents
EHEM van de Wall et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice
T Talsania et al.
ENDOCRINOLOGY (2005)
The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
CR Abbott et al.
BRAIN RESEARCH (2005)
Leptin-induced satiation mediated by abdominal vagal afferents
JH Peters et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Gastrointestinal mechanisms of satiation for food
RC Ritter
PHYSIOLOGY & BEHAVIOR (2004)
Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
B Ahrén
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients
A Sclafani et al.
PHYSIOLOGY & BEHAVIOR (2003)
Flavor preferences conditioned by intragastric fructose and glucose - Differences in reinforcement potency
K Ackroff et al.
PHYSIOLOGY & BEHAVIOR (2001)
Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms
B Balkan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2000)
The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor
M Nishizawa et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM (2000)
Share Paper
